{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:02:03Z","timestamp":1747170123081,"version":"3.40.5"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.retram.2024.103443","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T16:57:53Z","timestamp":1709312273000},"page":"103443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells"],"prefix":"10.1016","volume":"72","author":[{"given":"Ahmed B.","family":"Zaid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimaa K.","family":"Almady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samah M.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona G.","family":"Elabd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Saied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AbdulRahman A","family":"Saied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9297-8326","authenticated-orcid":false,"given":"Alshimaa M","family":"Elmalawany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2024.103443_bib0001","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.idc.2019.08.004","article-title":"Viral hepatitis","volume":"33","author":"Lanini","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.retram.2024.103443_bib0002","first-page":"1","article-title":"Epidemiology of hepatitis C in the Middle East","volume":"22","author":"Fallahian","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.retram.2024.103443_bib0003","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41598-017-17936-4","article-title":"Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions","volume":"8","author":"Kouyoumjian","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.retram.2024.103443_bib0004","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/ijms20061358","article-title":"Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis b and c infections: a Review","volume":"20","author":"Kanda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.retram.2024.103443_bib0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7314\/APJCP.2015.16.1.265","article-title":"Burden of Virus-associated Liver Cancer in the Arab World, 1990\u20132010","volume":"16","author":"Khan","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.retram.2024.103443_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.794","article-title":"Toxoplasma gondii, HBV, and HCV co-infection and their correlation with CD4 cells among Iranian HIV-positive patients","volume":"11","author":"Bazmjoo","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.retram.2024.103443_bib0007","first-page":"109","article-title":"Assessment of the sofosbuvir + daclatasvir (\u00b1) ribavirin treatment and the prognostic efficacy of interferon-gamma induced protein 10, macrophage inflammatory-1-beta, and C-reactive protein in Hepatitis C Egyptian patients\u2019 therapy outcome","volume":"6","author":"Ibrahim","year":"2022","journal-title":"BBRJ"},{"key":"10.1016\/j.retram.2024.103443_bib0008","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11904-010-0071-3","article-title":"HIV\/HCV Co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies","volume":"8","author":"Operskalski","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.retram.2024.103443_bib0009","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s11671-023-03895-5","article-title":"The potential of carbon-based nanomaterials in hepatitis C virus treatment: a review of carbon nanotubes, dendrimers and fullerenes","volume":"18","author":"Nader","year":"2023","journal-title":"Discover Nano"},{"key":"10.1016\/j.retram.2024.103443_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.882064","article-title":"Prevalence and outcome of serum autoantibodies in chronic Hepatitis C patients undergoing direct-acting antiviral treatment","volume":"13","author":"Romano","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2024.103443_bib0011","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.3390\/diagnostics13193102","article-title":"Molecular mechanisms of resistance to direct-acting antiviral (DAA) drugs for the treatment of Hepatitis C virus infections","volume":"13","author":"Izhari","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.retram.2024.103443_bib0012","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic Hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"New Eng J Med"},{"key":"10.1016\/j.retram.2024.103443_bib0013","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5144\/0256-4947.2023.308","article-title":"Experience with direct-acting antivirals in genotype 1\u20135 infected chronic hepatitis C patients in Turkey","volume":"43","author":"Sahin","year":"2023","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.retram.2024.103443_bib0014","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/13814788.2022.2056161","article-title":"Chronic hepatitis C: diagnosis and treatment made easy","volume":"28","author":"Abu-Freha","year":"2022","journal-title":"Euro J Gen Pract"},{"key":"10.1016\/j.retram.2024.103443_bib0015","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.3390\/cimb45100498","article-title":"Interferon-free regimens and direct-acting antiviral agents for delta hepatitis: are we there yet?","volume":"45","author":"Nemteanu","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.retram.2024.103443_bib0016","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5114\/ceh.2022.114246","article-title":"Successful treatment of hepatitis C genotype 4 using sofosbuvir, daclatasvir, simeprevir and ribavirin in Egyptian patients with direct-acting antiviral agent treatment failure","volume":"8","author":"Mohamed","year":"2022","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.retram.2024.103443_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43088-022-00337-6","article-title":"The relation between SNPs in the NME1 gene and response to sofosbuvir in Egyptian patients with chronic HCV","volume":"12","author":"AbdElrahman","year":"2023","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"10.1016\/j.retram.2024.103443_bib0018","doi-asserted-by":"crossref","unstructured":"AbdElrahman, M., Ibrahim, M.K., Tawfik, S., Omran, D., Bendary, M.M., Hassanin, S.O., & Elbatae H. The relation between SNPs in the NME1 gene and response to sofosbuvir in Egyptian patients with chronic HCV. Beni Suef Univ J Basic Appl Sci n.d.;12:2.","DOI":"10.1186\/s43088-022-00337-6"},{"key":"10.1016\/j.retram.2024.103443_bib0019","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.advms.2022.12.003","article-title":"Genotype 4 hepatitis C virus-a review of a diverse genotype","volume":"68","author":"Brzd\u0119k","year":"2023","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.retram.2024.103443_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00705-017-3573-0","article-title":"RETRACTED ARTICLE: efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice","volume":"163","author":"Abd-Elsalam","year":"2018","journal-title":"Arch Virol"},{"key":"10.1016\/j.retram.2024.103443_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43066-022-00174-3","article-title":"Efficacy and safety of sofosbuvir and daclatasvir in patients with chronic hepatitis C virus induced cirrhosis with child-pugh class B","volume":"12","author":"El Raziky","year":"2022","journal-title":"Egypt Liv J"},{"key":"10.1016\/j.retram.2024.103443_bib0022","doi-asserted-by":"crossref","first-page":"147","DOI":"10.48036\/apims.v19i2.838","article-title":"Syed mohsin naveed, mujeeb ur rehman. Response of daclatasvir and sofosbuvir in treatment-Na\u00c3\u00afve, HCV genotype 3, non-cirrhotic pakistani population: 1 year follow-up experience","volume":"19","author":"Islam","year":"2023","journal-title":"Annals PIMS-Shaheed Zulfiqar Ali Bhutto Med Univ"},{"key":"10.1016\/j.retram.2024.103443_bib0023","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/bbrj.bbrj_186_20","article-title":"Development of polyepitopic immunogenic contrast against hepatitis C virus 1a-6a genotype by in silico approach","volume":"4","author":"Dehghan","year":"2020","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"10.1016\/j.retram.2024.103443_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272582","article-title":"Design of a novel multi-epitope vaccine candidate against hepatitis C virus using structural and nonstructural proteins: an immunoinformatics approach","volume":"17","author":"Behmard","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.retram.2024.103443_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2023.1198361","article-title":"Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity","volume":"3","author":"Maretti-Mira","year":"2023","journal-title":"Front Virol"},{"key":"10.1016\/j.retram.2024.103443_bib0026","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/biom12010068","article-title":"Role of natural killer cells during pregnancy and related complications","volume":"12","author":"Mahajan","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.retram.2024.103443_bib0027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imm.13523","article-title":"The functional diversity of tissue-resident natural killer cells against infection","volume":"167","author":"Le","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.retram.2024.103443_bib0028","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/cei\/uxad050","article-title":"Protective and pathogenic functions of innate lymphoid cells in transplantation","volume":"213","author":"Mak","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.retram.2024.103443_bib0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12935-023-02996-6","article-title":"Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art","volume":"23","author":"Hatami","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.retram.2024.103443_bib0030","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037101","article-title":"Control of HCV infection by natural killer cells and macrophages","volume":"10","author":"Rosen","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.retram.2024.103443_bib0031","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14740\/gr1081w","article-title":"The influence of Hepatitis C viral loads on natural killer cell function","volume":"12","author":"Collister","year":"2019","journal-title":"Gastroenterology Res"},{"key":"10.1016\/j.retram.2024.103443_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02290","article-title":"NK cells in HIV-1 infection: from basic science to vaccine strategies","volume":"9","author":"Fl\u00f3rez-\u00c1lvarez","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2024.103443_bib0033","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/immuno1030021","article-title":"Role of KIR receptor in NK regulation during viral infections","volume":"1","author":"Rizzo","year":"2021","journal-title":"Immuno"},{"key":"10.1016\/j.retram.2024.103443_bib0034","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cells8040376","article-title":"Hepatitis C virus infection: host\u2013virus interaction and mechanisms of viral persistence","volume":"8","author":"Chigbu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.retram.2024.103443_bib0035","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.24556","article-title":"Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C","volume":"54","author":"Golden-Mason","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.retram.2024.103443_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250291","article-title":"Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct-acting antivirals","volume":"53","author":"Bi","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.retram.2024.103443_bib0037","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/vaccines11020408","article-title":"Innate and adaptive immunity during SARS-CoV-2 infection: biomolecular cellular markers and mechanisms","volume":"11","author":"Brown","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.retram.2024.103443_bib0038","first-page":"690","article-title":"Chronic hepatitis: morphology and nomenclature","volume":"7","author":"Ishak","year":"1994","journal-title":"Mod Pathol"},{"key":"10.1016\/j.retram.2024.103443_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350465","article-title":"Viral escape from NK-cell-mediated immunosurveillance: a lesson for cancer immunotherapy?","volume":"53","author":"Momayyezi","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.retram.2024.103443_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115136","article-title":"Intrinsic and extrinsic factors determining natural killer cell fate: phenotype and function","volume":"165","author":"Zhi","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.retram.2024.103443_bib0041","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/LVT.0000000000000139","article-title":"Immature and activated phenotype of blood NK cells is associated with acute rejection in adult liver transplant","volume":"29","author":"Song","year":"2023","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.retram.2024.103443_bib0042","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/cts.13208","article-title":"Natural killer cells in liver transplantation: can we harness the power of the immune checkpoint to promote tolerance?","volume":"15","author":"Halma","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.retram.2024.103443_bib0043","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/biom10111514","article-title":"The role of natural killer (NK) cells in acute coronary syndrome: a comprehensive review","volume":"10","author":"Kumri\u0107","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.retram.2024.103443_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108369","article-title":"Low-frequency, exhausted immune status of CD56dim NK cells and disordered inflammatory cytokine secretion of CD56bright NK cells associated with progression of severe HFMD, especially in EV71-infected patients","volume":"101","author":"Pan","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.retram.2024.103443_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.888248","article-title":"Natural killer cells in SARS-CoV-2 infection: pathophysiology and therapeutic implications","volume":"13","author":"Di Vito","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2024.103443_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148111","article-title":"Immune checkpoints on T and NK cells in the context of HBV infection: landscape, pathophysiology and therapeutic exploitation","volume":"14","author":"Dumolard","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2024.103443_bib0047","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0036-2023","article-title":"Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?","volume":"32","author":"Lepretre","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.retram.2024.103443_bib0048","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.31557\/APJCP.2021.22.8.2559","article-title":"The putative role of natural killer cells in patients with Hepatitis C virus-related hepatocellular carcinoma","volume":"22","author":"Hassouna","year":"2021","journal-title":"Asia Pacif J Cancer Prev"},{"key":"10.1016\/j.retram.2024.103443_bib0049","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3390\/diagnostics13132187","article-title":"Association of NK cells with the severity of fibrosis in patients with chronic Hepatitis C","volume":"13","author":"Kleczka","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.retram.2024.103443_bib0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jmv.21340","article-title":"Increased frequency of CD56 Bright NK-cells, CD3 \u2212 CD16 + CD56 \u2212 NK-cells and activated CD4 + T-cells or B-cells in parallel with CD4 + CDC25 High T-cells control potentially viremia in blood donors with HCV","volume":"81","author":"Zarife","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.retram.2024.103443_bib0051","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1413-8670(10)70082-9","article-title":"Interferon therapy shifts natural killer subsets among Egyptian patients with chronic hepatitis C","volume":"14","author":"Fathy","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.retram.2024.103443_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25375","article-title":"Liver cirrhosis in <scp>HIV<\/scp>\/<scp>HCV<\/scp>-coinfected individuals is related to <scp>NK<\/scp>cell dysfunction and exhaustion, but not to an impaired <scp>NK<\/scp>cell modulation by <scp>CD<\/scp>4 + T-cells","volume":"22","author":"Polo","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.retram.2024.103443_bib0053","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12964-023-01266-2","article-title":"Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?","volume":"21","author":"Razizadeh","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.retram.2024.103443_bib0054","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00284-022-03116-9","article-title":"Altered Signatures of plasma inflammatory proteins and phonotypic markers of NK Cells in kidney transplant patients upon CMV reactivation","volume":"80","author":"Soleimanian","year":"2023","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.retram.2024.103443_bib0055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.15789\/2220-7619-HCV-8047","article-title":"Features of NK cell phenotype virus genotype-driven chronic viral hepatitis C","volume":"13","author":"Savchenko","year":"2023","journal-title":"Russ J Infect Immun"},{"key":"10.1016\/j.retram.2024.103443_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.622306","article-title":"The role of natural killer cells in autoimmune diseases","volume":"12","author":"Kucuksezer","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2024.103443_bib0057","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-022-01058-z","article-title":"Natural killer cell homing and trafficking in tissues and tumors: from biology to application","volume":"7","author":"he","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.retram.2024.103443_bib0058","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41392-021-00613-4","article-title":"The STING1 network regulates autophagy and cell death","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.retram.2024.103443_bib0059","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3390\/cancers14051255","article-title":"Innate and adaptive immunopathogeneses in viral Hepatitis; crucial determinants of hepatocellular carcinoma","volume":"14","author":"Zaki","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.retram.2024.103443_bib0060","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.3390\/ijms20184569","article-title":"Liraglutide inhibits Hepatitis C virus replication through an AMP activated protein kinase dependent mechanism","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.retram.2024.103443_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100701","article-title":"Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years","volume":"5","author":"Graf","year":"2023","journal-title":"JHEP Reports"},{"key":"10.1016\/j.retram.2024.103443_bib0062","doi-asserted-by":"crossref","DOI":"10.1177\/13596535231189643","article-title":"Hepatitis C virus\/Hepatitis B virus co-infection: current prospectives","volume":"28","author":"Maqsood","year":"2023","journal-title":"Antivir Ther"},{"key":"10.1016\/j.retram.2024.103443_bib0063","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/jgh.16178","article-title":"Possible biological mechanisms of entecavir versus tenofovir disoproxil fumarate on reducing the risk of hepatocellular carcinoma","volume":"38","author":"Murata","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.retram.2024.103443_bib0064","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3748\/wjg.v29.i6.949","article-title":"Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C","volume":"29","author":"Brzd\u0119k","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.retram.2024.103443_bib0065","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1038\/s41467-022-35281-7","article-title":"Identification of human progenitors of exhausted CD8+ T cells associated with elevated IFN-\u03b3 response in early phase of viral infection","volume":"13","author":"Cai","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.retram.2024.103443_bib0066","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/jcm9041030","article-title":"Immunomodulation of the natural killer cell phenotype and response during HCV infection","volume":"9","author":"Njiomegnie","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.retram.2024.103443_bib0067","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/jiv391","article-title":"Immunological analysis during interferon-free therapy for chronic Hepatitis C virus infection reveals modulation of the natural killer cell compartment","volume":"213","author":"Spaan","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.retram.2024.103443_bib0068","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.3390\/ijms21207473","article-title":"Lymphocyte landscape after chronic hepatitis C virus (HCV) cure: the new normal","volume":"21","author":"Ghosh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.retram.2024.103443_bib0069","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep4.1166","article-title":"Early and late changes in natural killer cells in response to ledipasvir\/sofosbuvir treatment","volume":"2","author":"Golden-Mason","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.retram.2024.103443_bib0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3164\/jcbn.19-98","article-title":"Predictors of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting antiviral treatment: relationship with serum zinc","volume":"66","author":"Ozeki","year":"2020","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.retram.2024.103443_bib0071","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81801","article-title":"Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study","volume":"12","author":"Flower","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.retram.2024.103443_bib0072","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.31273","article-title":"Adaptive natural killer cell functional recovery in Hepatitis C virus cured patients","volume":"73","author":"Mele","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.retram.2024.103443_bib0073","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/cells10061332","article-title":"Natural killer cells and T cells in hepatocellular carcinoma and viral Hepatitis: current status and perspectives for future immunotherapeutic approaches","volume":"10","author":"Kalathil","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.retram.2024.103443_bib0074","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/17446651.2023.2248242","article-title":"Identification of individuals at risk of hepatocellular carcinoma: screening for clinically significant liver fibrosis in patients with T2DM","volume":"18","author":"Reinson","year":"2023","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.retram.2024.103443_bib0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12985-020-01449-0","article-title":"Role of \u03b3\u03b4 T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches","volume":"17","author":"Sabbaghi","year":"2020","journal-title":"Virol J"},{"key":"10.1016\/j.retram.2024.103443_bib0076","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.retram.2024.103443_bib0077","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00367","article-title":"The role of natural killer T cells in cancer\u2014A phenotypical and functional approach","volume":"9","author":"Krijgsman","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2024.103443_bib0078","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1093\/cid\/ciaa1443","article-title":"Double-blind, randomized, placebo-controlled trial with n-acetylcysteine for treatment of severe acute respiratory syndrome caused by coronavirus disease 2019 (COVID-19)","volume":"72","author":"de Alencar","year":"2021","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.retram.2024.103443_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijmr.ijmr_1250_23","article-title":"World Hepatitis Day 2023: are we close to the target?","volume":"158","author":"Hui","year":"2023","journal-title":"Ind J Med Res"},{"key":"10.1016\/j.retram.2024.103443_bib0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Nat Rev Immunol"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318624000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318624000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:54:31Z","timestamp":1726509271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318624000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2452318624000060"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2024.103443","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2024.103443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103443"}}